Definitive Healthcare Corp. has announced its financial results for the third quarter ended September 30, 2026, showcasing its performance in the competitive prepackaged software industry.

Company Overview

Definitive Healthcare Corp., trading under the ticker symbol DH on the Nasdaq, is a Delaware-based company that specializes in providing healthcare data solutions. The company operates under the Standard Industrial Classification (SIC) code 7372, which pertains to Services-Prepackaged Software. The firm has been actively filing reports with the SEC, including recent filings such as the 8-K on November 5, 2026, and a 10-Q on August 10, 2026.

What the Filing Says

In its recent 8-K filing, Definitive Healthcare announced, "On November 5, 2026, Definitive Healthcare Corp. issued a press release announcing its financial results for the third quarter ended September 30, 2026." The press release is included as Exhibit 99.1 in the filing.

Impact

The financial results disclosed in the filing may impact stakeholders, including investors, employees, and competitors within the prepackaged software industry. As Definitive Healthcare continues to grow, its performance could influence market trends and competitive strategies among similar firms.

What's Next

The filing does not say what happens next.

Financial Highlights

While the specific financial results for the third quarter were not detailed in the filing, it is noted that the press release accompanying the 8-K filing would provide comprehensive insights into the company's performance metrics, including revenue, net income, and other key financial indicators.

Company Contact Information

Definitive Healthcare Corp. is headquartered at 492 Old Connecticut Path, Suite 401, Framingham, Massachusetts, 01701. For inquiries, the company can be reached at (508) 720-4224.

Regulatory Compliance

The filing indicates that Definitive Healthcare Corp. is subject to the regulations of the Securities Exchange Act of 1934 and has been actively complying with its reporting obligations, as evidenced by its recent filings, including the 8-K and 10-Q reports.

Exhibits Included

The filing includes Exhibit 99.1, which is the press release detailing the financial results for the third quarter. This exhibit is crucial for stakeholders seeking detailed information about the company's operational performance during the specified period.

Additional Information

The filing does not provide specific financial figures or detailed analysis of the company's performance for the third quarter ended September 30, 2026. Further information regarding the company's financial condition and results of operations will be available in the press release and subsequent filings.